Schall, Brown & Schwartz LLP is reminding investors of a securities class action lawsuit against Hims & Hers Health, Inc. over alleged violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5. The proposed class covers investors who purchased HIMS shares from Aug. 4, 2025, through July 29, 2026, with a Nov. 2, 2026, deadline to contact the firm about possible lead plaintiff appointments. The complaint alleges that Hims & Hers provided customer health data to third-party advertising platforms, that its treatment practices were likely to draw increased regulatory scrutiny, and that its public statements were therefore false and materially misleading. The class has not yet been certified, and investors who take no action may remain absent class members.